NCT02080520View on ClinicalTrials.gov

Nattokinase Atherothrombotic Prevention Study

NACompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Prevention of Subclinical Atherosclerosis ProgressionPrevention of Cognitive Decline
Interventions
DIETARY_SUPPLEMENT

Nattokinase

OTHER

Placebo

Trial Locations (1)

90033

Atherosclerosis Research Unit, University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT02080520 - Nattokinase Atherothrombotic Prevention Study | Biotech Hunter | Biotech Hunter